NOTCH1 targeted siRNA therapies (Soluventis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNOTCH1 targeted siRNA therapies (Soluventis)
Drug Alias NameSoluventis-1Soluventis-2XD-00409
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionNeurogenic locus notch homolog protein 1 inhibitors
TargetsNeurogenic locus notch homolog protein 1
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSoluventis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSoluventis GmbH
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A